Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04788277 · ClinicalTrials.gov registry record
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
A clinical trial of Prostate Carcinoma, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- 675
- Enrollment target
- 1
- Study location
NCT04788277 is a study of Prostate Carcinoma that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 675 participants, below the 1,490-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04788277, a study of Prostate Carcinoma, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- 675 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the patients / volunteers.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 675 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04788277
The ClinicalTrials.gov registry entry for NCT04788277 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 675 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,490-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (55% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT04788277 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04788277 about?
NCT04788277 is a clinical study titled "Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)". The goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the patients / volunteer...
What is the current status of trial NCT04788277?
This trial is currently recruiting. The enrollment target is 675 participants. The study started on 2020-02-26. Estimated completion is 2026-12.
What conditions does trial NCT04788277 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT04788277?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04788277?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04788277 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
RECRUITING · NA
-
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
RECRUITING · Early Phase 1
-
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
RECRUITING · Phase 2
-
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
RECRUITING · Early Phase 1
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
RECRUITING · NA
-
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.